Hereditary endocrine growth disease
MONDO:0015514Also known as: genetic endocrine growth disease, growth disorder
196 clinical trials for this condition and its sub-types, 26 tagged with Hereditary endocrine growth disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Hereditary endocrine growth disease
-
Non-acquired pituitary hormone deficiency 0 trials · 85 incl. sub-types
5 sub-types
- Congenital hypogonadotropic hypogonadism 0 trials · 83 incl. sub-types Sub-types →
- Non-acquired combined pituitary hormone deficiency 1 trial · 3 incl. sub-types Sub-types →
- Isolated thyroid-stimulating hormone deficiency 1 trial
- Pituitary stalk interruption syndrome 1 trial
- Short stature due to GHSR deficiency 0 trials
-
Inherited primary ovarian failure 2 trials · 48 incl. sub-types
41 sub-types
- Turner syndrome 29 trials Sub-types →
- Ataxia telangiectasia 11 trials Sub-types →
- Classic galactosemia 3 trials
- Trisomy X 3 trials
- 46 XX gonadal dysgenesis 1 trial Sub-types →
- Congenital lipoid adrenal hyperplasia due to STAR deficency 1 trial Sub-types →
- Premature ovarian failure 1 1 trial Sub-types →
- 46,XX ovarian dysgenesis-short stature syndrome 0 trials
- Perrault syndrome 0 trials Sub-types →
- Satoyoshi syndrome 0 trials
- X small rings 0 trials
- Aromatase deficiency 0 trials
- Blepharophimosis, ptosis, and epicanthus inversus syndrome 0 trials Sub-types →
- Osteosclerosis-ichthyosis-premature ovarian failure syndrome 0 trials
- Premature ovarian failure 10 0 trials
- Premature ovarian failure 11 0 trials
- Premature ovarian failure 12 0 trials
- Premature ovarian failure 13 0 trials
- Premature ovarian failure 14 0 trials
- Premature ovarian failure 15 0 trials
- Premature ovarian failure 16 0 trials
- Premature ovarian failure 17 0 trials
- Premature ovarian failure 18 0 trials
- Premature ovarian failure 19 0 trials
- Premature ovarian failure 20 0 trials
- Premature ovarian failure 21 0 trials
- Premature ovarian failure 22 0 trials
- Premature ovarian failure 23 0 trials
- Premature ovarian failure 24 0 trials
- Premature ovarian failure 25 0 trials
- Premature ovarian failure 26 0 trials
- Premature ovarian failure 2A 0 trials
- Premature ovarian failure 2B 0 trials
- Premature ovarian failure 3 0 trials
- Premature ovarian failure 4 0 trials
- Premature ovarian failure 5 0 trials
- Premature ovarian failure 6 0 trials
- Premature ovarian failure 7 0 trials
- Premature ovarian failure 8 0 trials
- Premature ovarian failure 9 0 trials
- Tetrasomy X 0 trials
-
Congenital adrenal hyperplasia 36 trials · 38 incl. sub-types
8 sub-types
- Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency 20 trials Sub-types →
- Classic congenital adrenal hyperplasia 5 trials
- Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency 1 trial
- Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency 1 trial
- Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency 1 trial
- Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency 1 trial
- Congenital lipoid adrenal hyperplasia due to STAR deficency 1 trial Sub-types →
- Non-classic congenital adrenal hyperplasia 0 trials
-
Growth hormone insensitivity syndrome 0 trials · 6 incl. sub-types
6 sub-types
- Growth delay due to insulin-like growth factor I resistance 4 trials
- Growth delay due to insulin-like growth factor type 1 deficiency 1 trial
- Growth hormone insensitivity syndrome with immune dysregulation 0 trials · 1 incl. sub-types Sub-types →
- Laron syndrome 0 trials
- Short stature due to partial GHR deficiency 0 trials
- Short stature due to primary acid-labile subunit deficiency 0 trials
-
Permanent congenital hypothyroidism 1 trial · 3 incl. sub-types
2 sub-types
- Central congenital hypothyroidism 1 trial · 2 incl. sub-types Sub-types →
- Peripheral hypothyroidism 0 trials Sub-types →
-
Zerres Rietschel Majewski syndrome 0 trials
-
Microdontia hypodontia short stature 0 trials
Most studied deeper sub-types
-
Can a modified hydrocortisone mimic the Body's natural cortisol rhythm?
Disease control CompletedResearchers are testing Chronocort, a modified-release form of hydrocortisone, against standard immediate-release hydrocortisone in 30 healthy male volunteers. The study measures how the drug moves through the body, including how fast it reaches peak levels and how long it stays …
Phase 1 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a Timed-Release hydrocortisone pill match the Body's overnight hormone rhythm?
Disease control CompletedResearchers are testing several modified, timed-release versions of hydrocortisone, a hormone drug, in healthy male volunteers. The study has two parts: one compares how six different formulations move through the body after a single nighttime dose, and the other checks whether t…
Phase 1 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New pill could tame rare hormone disorder
Disease control CompletedThis study tested a new oral drug called atumelnant in 38 adults with classic congenital adrenal hyperplasia, a genetic condition causing hormone imbalances. The drug works by blocking a hormone receptor to lower excess adrenal hormones. Researchers measured safety, side effects,…
Phase 2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can a pill tame the relentless hunger of Prader-Willi syndrome?
Disease control CompletedThis phase 2 trial tests an oral drug called ARD-101 in adults with Prader-Willi syndrome, a genetic condition that causes an unrelenting feeling of hunger. Researchers give the drug twice daily for 28 days to see if it safely reduces hyperphagia, the intense drive to eat, using …
Phase 2 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Gene-Targeted obesity drug shows promise in phase 3 trial
Disease control CompletedThis phase 3 trial is testing a drug called setmelanotide in people with obesity linked to certain gene variants (POMC, PCSK1, LEPR, NCOA1, or SH2B1). About 296 participants, aged 6 to 65, will receive either the drug or a placebo to see if it helps reduce body weight. The study …
Phase 3 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a weekly shot replace daily growth hormone for kids?
Disease control CompletedThis study tests a new long-acting growth hormone called ACP-001, given as a once-weekly injection, in children with growth hormone deficiency. It compares the safety and effectiveness of this weekly shot to the standard daily growth hormone injections over six months. The goal i…
Phase 2 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Weekly shot could replace daily growth hormone injections for children
Disease control CompletedThis phase 3 trial tests a long-acting growth hormone called TransCon hGH, given as a once-weekly injection, in about 150 children with growth hormone deficiency. The study aims to see if the weekly shot is safe and helps children grow at a normal rate. All participants receive t…
Phase 3 • Sponsor: Ascendis Pharma Endocrinology Division A/S • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Weekly shot could replace daily needles for kids with growth hormone deficiency
Disease control CompletedThis phase 3 trial tests whether a once-weekly injection of TransCon hGH works as well as daily growth hormone injections in prepubertal children with growth hormone deficiency. About 150 children who have not received growth hormone treatment before will receive either the weekl…
Phase 3 • Sponsor: Ascendis Pharma Endocrinology Division A/S • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Weekly shot could replace daily needles for kids with growth hormone deficiency
Disease control CompletedThis study tests a long-acting growth hormone called TransCon hGH, given as a once-weekly injection, in children with growth hormone deficiency who have already completed a prior TransCon trial. The goal is to see if the weekly shot remains safe and effective over the long term. …
Phase 3 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Weekly shot could replace daily hormone injections for growth hormone deficiency
Disease control CompletedThis phase 3 trial investigates whether a once-weekly injection of lonapegsomatropin, a long-acting growth hormone, can safely and effectively treat adults with growth hormone deficiency. The study compares the weekly drug against a placebo and a standard daily growth hormone pro…
Phase 3 • Sponsor: Ascendis Pharma Endocrinology Division A/S • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can a simple supplement boost birth weight? new study hopes so
Disease control CompletedThis study tested whether giving pregnant women a balanced energy and protein supplement (BEP) can improve birth weight and reduce complications like low birth weight and preterm birth. Over 3,300 women in Bangladesh were randomly assigned to receive either BEP or standard prenat…
Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a daily pill replace growth hormone shots for children?
Disease control CompletedThis study tests an oral medication called LUM-201 in children with growth hormone deficiency who have not yet received treatment. The goal is to see if taking a pill daily can improve growth as effectively as standard daily injections. The trial also looks for a way to identify …
Phase 2 • Sponsor: Lumos Pharma • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hormone treatment shows promise for rare adrenal disorder
Disease control CompletedThis study looked at the long-term safety of a medication called Chronocort in 76 people aged 16 and older with congenital adrenal hyperplasia (CAH), a condition where the body can't make enough cortisol. Researchers monitored for signs of over- or under-treatment, adrenal crises…
Phase 3 • Sponsor: Immedica Pharma AB • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Eggs and parenting: a recipe for healthier babies?
Disease control CompletedThis study tested whether giving babies one egg daily along with teaching parents about responsive feeding, nutrition, and hygiene can improve growth and development. 600 infants in Haiti were split into three groups: standard care, eggs only, or eggs plus the parenting program. …
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Frozen ovary tissue awakened to restore fertility in women with early menopause
Disease control CompletedThis study tested a new technique to help women with primary ovarian insufficiency (early ovarian failure) become pregnant. Doctors removed one ovary, treated small pieces of it with drugs to wake up dormant eggs, and then transplanted the tissue back into the patient. After moni…
Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Once-a-Week needle could replace daily pokes for growth hormone deficiency
Disease control CompletedThis study tested a new growth hormone medicine, somapacitan, given once a week, against the standard daily Norditropin in 200 children with growth hormone deficiency. After one year, children receiving the weekly shot grew just as much in height as those on daily shots, with sim…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a pill replace daily shots for growth hormone deficiency?
Disease control CompletedThis study tested an oral drug called LUM-201 in 15 children with growth hormone deficiency who had already received daily injections for a year. The goal was to see if LUM-201 could maintain or improve growth over 12 months. The drug was given once daily by mouth, and researcher…
Phase 2 • Sponsor: Lumos Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could red blood cells deliver a steroid to ease a rare brain disorder?
Disease control CompletedThis Phase 3 trial tested a treatment called EryDex for people with ataxia telangiectasia (A-T), a rare genetic disease that affects movement and coordination. EryDex is a steroid (dexamethasone) packaged inside the patient's own red blood cells and given as an IV infusion every …
Phase 3 • Sponsor: Quince Therapeutics S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Can fortified foods help Zimbabwe's children grow stronger?
Disease control CompletedThis study tested whether adding extra nutrient-rich foods to infants' diets can help them get enough energy and nutrients to prevent stunting. 192 infants in rural Zimbabwe received either standard fortified supplements or an enhanced mix including orange maize, beans, moringa, …
Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Weekly shot could replace daily needles for kids with growth hormone deficiency
Disease control CompletedThis study tested a new once-weekly growth hormone injection (somapacitan) against the standard daily growth hormone shot in 76 children with growth hormone deficiency who had never been treated before. The main goal was to see how well the weekly shot worked for height growth an…
Phase 2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Growth hormone trial aims to boost muscle in Prader-Willi patients
Disease control CompletedThis completed Phase 3 study tested somatropin, a synthetic growth hormone, in 33 Japanese children and adults with Prader-Willi syndrome. The goal was to see if it safely improves body composition by increasing lean body mass and reducing fat. Participants were divided into thre…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Weekly shot may replace daily needle for kids with growth hormone deficiency
Disease control CompletedThis study tested a new medicine, somapacitan, given once a week against the standard daily growth hormone shot (Norditropin®) in 110 Chinese children with growth hormone deficiency. The goal was to see if the weekly shot works as well as the daily one for helping children grow. …
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Home health visitors show promise for moms and kids in rural south africa
Disease control CompletedThis study tested whether trained community health workers visiting pregnant women at home could improve health for both mothers and children in a rural area of South Africa. The program focused on supporting women with HIV, depression, or alcohol use, and on improving child grow…
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can growth hormone make short boys stronger?
Disease control CompletedThis study looked at whether growth hormone therapy can improve muscle strength, power, and body composition in short prepubertal boys, both those with growth hormone deficiency and those with idiopathic short stature. Thirty short boys received growth hormone injections for 12 m…
Sponsor: Nemours Children's Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New hope for kids with rare sugar disorder: drug shows promise in trial
Disease control CompletedThis study tested an experimental drug called AT-007 in 47 children aged 2 to 18 with Classic Galactosemia, a rare genetic disorder that makes it hard to break down a sugar called galactose. The goal was to see if the drug could improve behavior, daily living skills, and language…
Phase 2/3 • Sponsor: Applied Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug shows promise for rare hormone disorder
Disease control CompletedThis phase 2 trial tested a new drug called SPR001 in 24 adults with classic congenital adrenal hyperplasia (CAH), a genetic condition that disrupts hormone production. The study aimed to see if SPR001 is safe and can improve hormone control. Participants took multiple doses of t…
Phase 2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New lifestyle program aims to help Prader-Willi patients keep weight off
Disease control CompletedThis completed trial tested a personalized program of physical activity, nutrition guidance, and education for 128 adults with Prader-Willi syndrome. Participants followed the program during a 5-week hospital stay, with the goal of stabilizing or reducing their body mass index (B…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Babble boot camp: could early talk therapy stop speech delays in rare disease?
Prevention CompletedThis study tested a program called Babble Boot Camp for babies with classic galactosemia, a rare condition that often causes speech and language problems. The program started when babies were 2 to 24 months old and involved weekly online coaching for parents from a speech therapi…
Early phase 1 • Sponsor: Arizona State University • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
Cash and coaching: a recipe to fight malnutrition?
Prevention CompletedThis completed trial in Somalia tested whether giving families cash transfers, with or without extra nutrition education and additional cash, could prevent malnutrition in children and mothers. Over 3,300 families received monthly mobile cash for 6 months. Researchers measured wa…
Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jun 26, 2026 14:48 UTC
-
Can an immune drug slow a rare childhood brain disease?
Symptom relief CompletedAtaxia-telangiectasia is a rare, inherited disease that damages the nervous system, skin, and immune system, and it has no cure. Researchers are testing sirolimus, an immune-suppressing drug, in children under 17 with the condition. The six participants take sirolimus by mouth fo…
Phase 2 • Sponsor: Sara Elva Espinosa Padilla, MD • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can a wakefulness drug beat daytime sleepiness in Prader-Willi syndrome?
Symptom relief CompletedThis phase 2 study tested whether pitolisant, a drug that promotes wakefulness, can safely reduce excessive daytime sleepiness in people with Prader-Willi syndrome. The trial enrolled 65 participants aged 6 to 65 and compared pitolisant to a placebo over 11 weeks, followed by an …
Phase 2 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Can a 'Love Hormone' spray tame Prader-Willi symptoms?
Symptom relief CompletedThis study tested whether oxytocin nasal spray, sometimes called the 'love hormone,' can improve behavior and eating problems in adults with Prader-Willi syndrome. Fifty participants received either oxytocin or a placebo daily or every three days for 28 days. Researchers measured…
Phase 2/3 • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Can farming plus nutrition help stop child stunting? kenya study finds out.
Knowledge-focused CompletedThis study looked at whether adding nutrition and hygiene support to an existing farming program can reduce malnutrition in pregnant women and their children. About 1,200 pregnant women in Kenya took part, with half getting the extra nutrition help. The goal was to see if childre…
Sponsor: Fabian Rohner • Aim: Knowledge-focused
Last updated Sep 21, 2026 14:00 UTC
-
Would families trade daily growth hormone shots for weekly ones?
Knowledge-focused CompletedChildren with growth hormone deficiency often need daily injections, which can be hard to keep up with. Researchers in Belgium and Luxembourg are asking families in the BELGROW registry to fill out a questionnaire about whether they would consider switching to long-acting growth …
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Knowledge-focused
Last updated Sep 21, 2026 14:00 UTC
-
Rare disease mystery: NIH launches deep dive into Smith-Magenis syndrome
Knowledge-focused CompletedThis study follows nearly 600 people with Smith-Magenis syndrome (SMS), a rare genetic condition, to track how their health, behavior, and development change over time. Researchers will perform detailed medical exams, genetic tests, and surveys to better understand the syndrome's…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Scientists unravel mysteries of puberty and fertility hormone
Knowledge-focused CompletedThis study looked at people with low or no GnRH, a hormone that controls puberty and fertility. Researchers studied 111 adults and teens to understand how GnRH problems affect the body. The goal was to find new hormone patterns and genetic causes, not to test a treatment.
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can Practice-Based training boost caregiver skills for stunted children?
Knowledge-focused CompletedThis study tests whether adding hands-on, simulation-based training to standard educational materials improves the caregiving skills of families with stunted children aged 1-3 years. Caregivers receive either a take-home module alone or the module plus guided practice sessions. T…
Sponsor: Universitas Muhammadiyah Tasikmalaya • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Can brain tests unlock the social struggles of turner syndrome?
Knowledge-focused CompletedThis study investigates why some girls with Turner syndrome find it hard to make friends, read emotions, and control their feelings. Researchers will compare 35 girls with Turner syndrome to 35 girls with isolated growth hormone deficiency, all aged 7 to 16. Through puzzles, memo…
Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Scientists dig into the mysteries of x and y chromosomes
Knowledge-focused CompletedThis study looked at 112 people with known differences in their sex chromosomes (X and Y) to better understand how these variations affect health, especially infertility. Participants underwent physical exams, blood and urine tests, imaging, and sensory checks over about 5 days. …
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Antipsychotic side effects in kids: new study probes hormone disruption
Knowledge-focused CompletedThis study looked at 90 children and teens (ages 7-18) taking antipsychotic medication to see how it affects their hormones, growth, and metabolism. Researchers measured prolactin levels and checked for links to sex hormones, metabolic health, and puberty development. The goal wa…
Sponsor: Ulla Schierup Nielsen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Hormone study aims to unlock Prader-Willi feeding mystery
Knowledge-focused CompletedThis completed study looked at how appetite-regulating hormones change in infants with Prader-Willi syndrome during the first four years of life. Researchers collected blood samples from 215 infants to understand why they switch from poor feeding to severe overeating and obesity.…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Italian study checks how well newborn screening detects rare hormone disorder
Knowledge-focused CompletedThis completed study looked at newborn screening for congenital adrenal hyperplasia (CAH) in Italy. Researchers reviewed medical records of 29 infants diagnosed with classic CAH between 2006 and 2019 to see how accurate the screening was. The goal was to measure the screening's s…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Large study looks at how a 25-Gene cancer test affects patients and families
Knowledge-focused CompletedThis study looked at how a genetic test that checks 25 genes linked to hereditary cancers is used in clinics. Over 1,500 people with a personal or family history of cancer took part. Researchers collected blood samples and had participants fill out questionnaires over five years …
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Snap a pic, check growth: AI could replace the measuring tape for kids
Knowledge-focused CompletedThis completed study tested whether artificial intelligence (AI) can accurately estimate a child's height and weight just from photos. Researchers took pictures of 250 children aged 2 to 6 years old, both in clinics and at home. The AI's estimates were then compared to actual phy…
Sponsor: Danone Asia Pacific Holdings Pte, Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Can a diabetes drug reveal hidden hormone deficiencies?
Knowledge-focused CompletedThis study tested whether people with hypopituitarism (a condition where the pituitary gland doesn't work properly) have lower oxytocin levels compared to healthy individuals. Researchers gave participants a drug called exenatide (a GLP1 receptor agonist) to see if it could stimu…
Phase 4 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Brain scan grading predicts growth problems in child tumor survivors
Knowledge-focused CompletedThis study looked at 500 children who had surgery for a rare brain tumor called craniopharyngioma. Researchers used MRI scans to grade how much the tumor damaged a key brain area (the hypothalamus). They found that more damage was linked to higher rates of growth hormone deficien…
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Study reveals key insights for safer cochlear implants in kids with rare CHARGE syndrome
Knowledge-focused CompletedThis study reviewed medical records of 12 children with CHARGE syndrome who had cochlear implant surgery. Researchers looked at their ear bone structure and surgical challenges to find ways to make the operation safer. The goal is to help surgeons better prepare for the unique an…
Sponsor: Seoul National University Bundang Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Simple blood test may spot hidden blood vessel damage in kids with growth issues
Knowledge-focused CompletedThis completed study looked at whether a blood test for a substance called ADMA can measure blood vessel health in children with growth hormone deficiency or those born small for their age. Researchers compared ADMA levels to ultrasound measurements of artery function in 23 child…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Prenatal steroid for CAH: safe for the brain? new study investigates
Knowledge-focused CompletedThis study evaluates the long-term cognitive development of children who were exposed to dexamethasone (a steroid) while in the womb because they were at risk for congenital adrenal hyperplasia (CAH). The goal is to see if the drug causes any thinking or memory problems. Research…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
New tool aims to customize growth hormone therapy for children
Knowledge-focused CompletedThis completed study involved 40 families of children with growth hormone deficiency. Researchers used data from connected injector devices and family surveys to develop a personalized growth hormone treatment profile (PGTP) report. The goal is to help doctors create more tailore…
Sponsor: Luis Fernandez Luque • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Could a simple drink before pregnancy shape your child's future health?
Knowledge-focused CompletedThis study followed 461 children whose mothers took a special nutritional drink before and during pregnancy. Researchers want to understand how parents' diet, lifestyle, and metabolism influence child growth, thinking skills, and overall well-being. The goal is to identify factor…
Sponsor: University of Southampton • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Rare enzyme Disorder's blood pressure mystery probed
Knowledge-focused CompletedThis completed study investigated why patients with Cytochrome P450 Oxidoreductase (POR) deficiency, a rare genetic condition, often develop high blood pressure and blood vessel damage. Researchers compared 51 participants (patients and healthy controls) using 24-hour blood press…
Sponsor: Ozge Bayrak Demirel • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:41 UTC
-
Growth hormone may turn back the clock in kids – but Don't get excited yet
Knowledge-focused CompletedThis study measured the biological (epigenetic) age of 10 children with growth hormone deficiency before and after 6 months of hormone therapy. Researchers wanted to see if treatment changes how old their cells appear. The goal is to better understand growth hormone's effects on …
Sponsor: Istituto Auxologico Italiano • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:45 UTC